ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Recurrence
Adenocarcinoma
Breast Cancer

Prostate Cancer trials near Phoenix, AZ, USA:

Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer (PrTK03)

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Phoenix, Arizona, United States and 72 other locations

to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...

Enrolling
Prostate Cancer
Drug: AAA617

Phase 4

Novartis
Novartis

Scottsdale, Arizona, United States and 53 other locations

of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Biological: vudalimab monotherapy
Combination Product: vudalimab + carboplatin + cabazitaxel

Phase 2

Xencor
Xencor

Phoenix, Arizona, United States and 25 other locations

Status recently updated

This is a Phase 1a, first-in-human, open-label dose-escalation study to determine the RDR and/or MTD, and to assess the DLT of INV-9956. The safety,...

Not yet enrolling
Enrolling
Advanced Metastatic Castration Resistant Prostate Cancer
Drug: INV-9956

Phase 1

Shenzhen Ionova Life Sciences

Scottsdale, Arizona, United States and 3 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Prednisone
Drug: Placebo

Phase 2, Phase 3

Lilly
Lilly

Phoenix, Arizona, United States and 112 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Enrolling
Prostate Cancer
Device: Vanquish System
Francis Medical

Phoenix, Arizona, United States and 32 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Chandler, Arizona, United States and 388 other locations

in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...

Active, not recruiting
Prostatic Neoplasms
Drug: Bicalutamide Placebo
Radiation: 74-80 Grays (units of radiation)

Phase 3

Aragon Pharmaceuticals

Scottsdale, Arizona, United States and 271 other locations

activity of RO7656594 in participants with advanced or metastatic prostate cancer. It will also identify recommended doses and regi...

Enrolling
Metastatic Prostate Cancer
Advanced Prostate Cancer
Drug: RO7656594

Phase 1

Genentech
Genentech

Scottsdale, Arizona, United States and 16 other locations

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetax...

Enrolling
Prostate Cancer
Drug: Radium-223
Drug: Docetaxel 60 mg/m2

Phase 3

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Gilbert, Arizona, United States and 68 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems